ACCELERATING
THE NEXT
FRONTIER OF
INNOVATION

We invest in 
frontier technology
companies that use innovative science and deep technology to address some of the world’s most pressing challenges.

From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.

Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.

These contrarian solutions may seem crazy today but will feel obvious in hindsight.

That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.

From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.

Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.

These contrarian solutions may seem crazy today but will feel obvious in hindsight.

That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.

From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.

Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.

These contrarian solutions may seem crazy today but will feel obvious in hindsight.

That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.

From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.

Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.

These contrarian solutions may seem crazy today but will feel obvious in hindsight.

That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.

We invest in frontier technology companies that use innovative, science-based and deep technology to address some of the world’s most pressing challenges.

From fighting climate change to treating disease to meeting the world’s insatiable demand for compute, these challenges need urgent answers.

Addressing them will require bold, technical solutions that work on a massive scale -- creating the next trillion dollar opportunities.

These contrarian solutions may seem crazy today but will feel obvious in hindsight.

That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.

We invest in innovative, science-based and deep technology companies addressing some of the world’s most pressing challenges — from fighting climate change to finding cures for untreatable diseases to feeding the global population.

These challenges need urgent answers and solving them will create the next trillion dollar opportunities.

The solutions to today’s challenges won’t look like yesterday’s.

Software alone will only get us so far.

Addressing our most entrenched problems will take deeply technical innovations that work on a massive scale.

These contrarian solutions may seem crazy today but will feel obvious in hindsight.

That’s why we’re investing at the frontier and supporting entrepreneurs as they build the companies that will define new categories and drive the next revolutions.

Juvena is proud to be partnered with Bison Ventures. Bison’s experience and passion for using innovative science and technology to accelerate the discovery and development of novel therapeutics makes them an ideal partner for us.

Hanadie Yousef
CEO of Juvena Therapeutics
Hanadie Yousef
CEO of Juvena Therapeutics

Ben and Tom are highly experienced and exceptionally talented investors who were strongly committed to the success of Schrodinger and who provided invaluable advice that helped the company excel and grow.

Ramy Farid
CEO of Schrodinger
Ramy Farid
CEO of Schrodinger

Tom’s unique combination of technical background and investing acumen was a major asset for Ginkgo. He was a valuable voice in the board room that was both supportive and constructive.

Jason Kelly
CEO of Ginkgo Bioworks
Jason Kelly
CEO of Ginkgo Bioworks

Juvena is proud to be partnered with Bison Ventures. Bison’s experience and passion for using innovative science and technology to accelerate the discovery and development of novel therapeutics makes them an ideal partner for us.

Hanadie Yousef
CEO of Juvena Therapeutics
Hanadie Yousef
CEO of Juvena Therapeutics